A

Ambiopharm - A Global Peptide CdmoPharmaceutical Manufacturing · 501-1000 · B2B contacts & data

13 Decision makers
+1 New (6 months)
1,000 Employees
$65M Revenue
2005 Founded

Decision Makers at Ambiopharm - A Global Peptide Cdmo

Total identified

13 decision makers identified 2 C-Level 3 VP 8 Heads

New decision makers — last 6 months

+1 a strong signal to time your outreach 1 Heads
Preview available contacts
Decision maker Email Phone

Create a free Zeliq account to access their verified emails and direct phone numbers.

See 13 decision makers on Zeliq →

Organizational Chart of Ambiopharm - A Global Peptide Cdmo

Roles identified within Ambiopharm - A Global Peptide Cdmo's leadership team, based on public professional data.

Ambiopharm - A Global Peptide Cdmo's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Team Structure headcount by department

Research
38
Operations
21
Technical
12
Project Management
9
Finance
7
General Management
6
HR
6
Other
6

Funding

Last round Private equity · $0
Total funding $24M (2 rounds)
Venture Round $24M Nov 2014
Private Equity Round N/A Sep 2018

Companies similar to Ambiopharm - A Global Peptide Cdmo

Latest news at Ambiopharm - A Global Peptide Cdmo

  1. Appointment

    New Associate Director Facilities appointed — Engineering and technical

    Get email and phone via Zeliq →

About Ambiopharm - A Global Peptide Cdmo

Ambiopharm - A Global Peptide Cdmo is a company active in the Pharmaceutical Manufacturing space, operating from United States. Founded in 2005, the company has a workforce of roughly 1,000 people. Ambiopharm - A Global Peptide Cdmo belongs to the Manufacturing sector, with a specific positioning on Pharmaceutical Manufacturing. Its customer base is mainly professional: Ambiopharm - A Global Peptide Cdmo operates on a B2B model. The company has secured 2 rounds of funding totalling $24M. Annual revenue is estimated at around $65M. The data below (industry, headcount, location and business signals) helps sales teams qualify Ambiopharm - A Global Peptide Cdmo and pinpoint the right decision makers from the first touchpoint.

Activity & Market

The company evolves in the Pharmaceutical Manufacturing segment of the Manufacturing sector. As a B2B company, Ambiopharm - A Global Peptide Cdmo primarily serves business clients and professional organisations. In terms of structure, it is registered as “Privately held”.

How to prospect Ambiopharm - A Global Peptide Cdmo's departments

Research

The company's largest department, with 38 people. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Operations

With 21 people, this is the organisation's second pillar. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Technical

12 people work in this department. Technical teams verify claims: public docs, a sandbox or a free tier will do the selling for you.

Project Management

A team of 9 people. These profiles own delivery: anything that de-risks a milestone gets their attention.

Finance

This department counts 7 people. Timing matters here: approach them around budget planning cycles, when arbitrations are actually open.

General Management

6 people work in this department. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

FAQ Ambiopharm - A Global Peptide Cdmo

What industry does Ambiopharm - A Global Peptide Cdmo operate in?

Ambiopharm - A Global Peptide Cdmo operates in the Pharmaceutical Manufacturing industry, specifically in the Manufacturing category.

How many employees does Ambiopharm - A Global Peptide Cdmo have?

Ambiopharm - A Global Peptide Cdmo has approximately 1,000 employees (in the 501-1000 range). This figure is an estimate to help qualify the account, not a legally certified number.

How do I find contacts at Ambiopharm - A Global Peptide Cdmo?

With Zeliq, you can find the right decision makers at Ambiopharm - A Global Peptide Cdmo, get their verified emails and direct phone numbers, and engage them through targeted multichannel sequences.

Where is Ambiopharm - A Global Peptide Cdmo headquartered?

Ambiopharm - A Global Peptide Cdmo is headquartered in United States.

What is the organizational chart of Ambiopharm - A Global Peptide Cdmo?

Based on public professional data, Ambiopharm - A Global Peptide Cdmo's organizational chart includes roles such as CFO, CEO, VP of Sales, VP of Project Management, Director Sales Europe, Director of Engineering & Capital Projects. Zeliq lets you find the verified contact details behind each of these roles.

Which decision makers recently joined Ambiopharm - A Global Peptide Cdmo?

In the last 6 months, Ambiopharm - A Global Peptide Cdmo appointed new decision makers including Associate Director Facilities. Newly appointed leaders typically review tools and vendors early on — their verified contacts are available on Zeliq.

Why use this data before prospecting Ambiopharm - A Global Peptide Cdmo?

With Ambiopharm - A Global Peptide Cdmo's firmographics and business signals at hand, you can prioritise the account, personalise your approach, and contact the right people straight away.